Skip to main content

Covid-19 HSE Clinical Guidance and Evidence

* Phone users, please scroll down to view content. Queries to:

Residential Services Evidence: Summary of Evidence

Specific requirements or considerations for patients >65 with COVID-19? - Updated March 23rd - Download evidence abstract  - Download summary of evidence 

Residential Services


One page workflows:

Preliminary Clinical and Infection Control Guidance for COVID-19 in nurse- led Residential Care Facilities (RCF) (CD19-001. V1/19_03_2020)

​​Criteria for patients with Covid 19 who are suitable for home care (Download of assessment form).

  • Suitability for discharge
  • Discharge standards and follow up plan
  • Rehabilitation
  • Psychological intervention
  • Support post-discharge.
  • Rehabilitation
  • Serology testing
  • Immunity following infection

​Preliminary Clinical and Infection Control Guidance for Covid-19 in nurse- led Residential Care Facilities (RCF) Updated 17/03/2020


Data from international Covid outbreaks has identified significant levels of mortality and morbidity in high-risk groups. Therefore, particular attention is required in RCFs where significant numbers of vulnerable people are managed to support prevention, identification and clinical management scenarios arising within them. Structured approaches to supportive care, anticipatory planning and palliative care may also affect the course and disease outcomes although evidence at this stage of the outbreak is limited in this regards. Be aware that within the changing nature of the epidemic clinical guidance regarding management may change quite quickly and keep updated with relevant sites at and

Who is this guidance intended for?

Clinicians (nursing and medical) and managers delivering care in residential care facilities where the main model of care delivery is nurse-led. This includes

  • Residential care facilities for older persons (Public, Private and voluntary)
  • Disability-care settings (including congregated settings) primarily nurse-led
  • Long-term mental health settings e.g. Specialist Older persons Mental Health care services, approved centres

2. General Measures to reduce the risk of accidental introduction of Covid-19 into a Residential Care Facility

Close attention to national guidance set out on preventative measures for Covid-19 by all staff, residents and visitors on including

  • Careful attention to hand hygiene with provision of hand sanitiser and or hand washing facilities at all entrances (where practical to provide sinks)
  • Coughing / Sneezing into tissue / elbow crook
  • Visitor notices advising of hand hygiene measures before, during and after visiting
  • Visitor notices advising against visitors attending if they have been in contact with COVID-19 cases and if they have fever or symptoms of respiratory tract infection and until at least 48 hours after symptoms have resolved
  • Appropriate visitor restrictions in event of COVID- 19 outbreak
  • Appropriate Social Distancing measures being observed by staff and as appropriate for residents within facilities where clinically appropriate
  1. Regular infection prevention and control training for staff with emphasis on Standard Precautions (including hand hygiene) and including the appropriate use of personal protective equipment. Training should include donning (putting on) and doffing (taking off) of PPE when required.
  2. Prepare a facility preparedness plan that reflects staff training in IPC measures, contingency planning for outbreak management including isolation measures and cleaning procedures.
  3. Outward transfer of residents for attendance or care off site should be minimised.

General advice regarding care of residents infected during COVID-19 epidemic

  1. In general, residents in residential care who are COVID-19 Positive should be managed in their facilities.
  2. Transfer to hospital is only appropriate where this will confer additional benefit. Decisions to transfer should be discussed in advance with senior clinician (DON / ADON /PIC) in conjunction with GP/MO/OOH and should be made in conjunction with the person, their families and their advanced care plans.
  3. Ensure as far as possible that discussions with residents and families reflecting care preferences including at end of life have been identified, documented and updated. Be aware that significant and rapid clinical change can be a feature of COVID-19 disease in some older adults and encourage timely discussions in line with same.
  4. Decisions regarding care should be individualised to the resident.
  5. Seek advice from relevant acute hospital clinicians, older persons’ specialist services and palliative care services when appropriate. This may assist with ongoing clinical management and inform decisions re clinical appropriateness of potential decisions regarding transfer
  6. Close the RCF to all new admissions during time of outbreak
  7. Proactively manage communications with residents, staff, families and others. Refer all for guidance from and

Where resident presents as clinically suspect for COVID-19 status procedures to be applied:

  1. As per current HPSC guidance suspected cases of COVID-19 based on clinical criteria of respiratory illness and / or fever and / or influenza like illness should be advised to the facility’s GP / MO in the first instance.
  2. Following risk assessment the GP/ MO /OOH can contact the National Ambulance Service to request COVID-19 home assessment and testing on electronic health referral.
  3. Senior clinicians (such as Directors of Nursing / assistant Directors of Nursing/ Person In Charge) within RCFs should be involved in all discussions with GPs regarding referral of potential cases and appropriate discretion used in the application of clinical criteria to residents being referred for testing. 19%20Risk%20Assessment%20and%20Management%20of%20patients%20who%20ph one%20v3.0.pdf.

  1. All RCF are advised to isolate possible COVID-19 cases while awaiting results with precautions as advised in current HPSC guidance using Contact and Droplet Precautions in addition to Standard Precautions
  2. Any resident requiring hospitalisation who they believe may have COVID-19 19 should be flagged with the receiving hospital beforehand.

Common Symptoms and Signs indicative of possible Covid-19 illness:

Most common:


Shortness of breath

Myalgia (Aches & Pains)





Less common:


Sputum production

Sore throat




Conjunctival congestion

Chest pain



Nausea/ vomiting

Abdominal pain


Risk factors for severe disease:

Ischaemic heart disease

Chronic heart failure



Chronic lung disease

1o or 2o immunosuppression


Age > 75



Red flags: Urgent Medical/Senior Clinician Review required

RR > 30breathes/min

Severe respiratory distress

New onset SpO2 < 90% on room air

New onset confusion


Oliguria > 12 hours


Clinical Investigations supporting diagnosis of Covid-19

Throat and nose swab for laboratory detection of virus RNA is the method used to confirm the diagnosis. Although the test is considered generally reliable when taken in symptomatic people the test is not perfect and reliability depends on sample quality (a properly taken swab). Where there is a high clinical index of suspicion for COVID-19 (e.g. during facility outbreak), failure to detect the virus in a nose / throat swab does not entirely exclude the possibility of COVID-19.

Note also that if a resident has a clinical picture of viral respiratory tract infection, even if they do not have COVID-19 they are likely to be infected with another virus that can spread to other residents therefore additional infection prevention and control precautions remain appropriate until the resident has recovered.

On confirmation of a diagnosis of COVID-19 further investigations may be considered appropriate to assist with management. e.g. FBC, UEC, LFTs, CXR

Investigations to out-rule underlying non-COVID-19 related conditions may be appropriate

Clinical discretion and judgement should be used regarding further investigation and in particular in identifying whether same will alter overall patient management and risks posed by transfer to and from acute hospital facilities for same

Clinical Monitoring and management of patients with suspected or confirmed Covid-19 status in RCF

  • Monitoring of vital signs by pulse oximetry, BP, RR, Temp on twice daily basis / as determined in conjunction with GP/ MO or other medical advice
  • Monitor for common symptoms identified above and treat accordingly with supportive measures including paracetamol and oxygen, nasal prongs where appropriate
  • Optimise and encourage good oral fluid and nutritional intake
  • Use clinical judgement regarding appropriateness of monitoring where there is an expected change in the patient’s clinical condition
  • Rapid and unexpected change in clinical status may occur (typically days 7-9). Ensure insofar as possible that appropriate measures to ensure comfort are made available and that staff are aware and trained in meeting resident’s needs to cater for this situation.
  • Develop an anticipatory care plan with resident and / or family member using national palliative guidance and ethical framework.
  • Put a supportive palliative management plan in place (with anticipatory prescribing measures) for care towards end of life in nursing home where this has been agreed as the preferred option for individual residents within an agreed management plan. (Separate guidance to be issued supporting EOL symptom management).

Decision algorithm in regards to escalation reflecting anticipatory guidance

The following anticipatory decision log below is to offer guidance to doctors and nurses who may not be familiar with the resident as to what approach to take in the event of their acute deterioration. This document cannot cover all clinical eventualities but it may act as a guide in deciding the appropriateness of certain interventions. It is not prescriptive. The treating clinician should use their discretion to provide whatever treatment they see fit, depending on the clinical scenario. All residents, at all times, are entitled to access immediate medical care to alleviate distress.








Attempt CPR







IV/SC Fluids








Yes/only if aids symptoms

Yes/only if aids symptoms

Yes/only if aids symptoms

Yes/only if aids symptoms

Yes/only if aids symptoms

Yes/only if aids symptoms

Transfer          to Acute Hospital















  1. Infection Prevention and Control Measures Management of staff contacts in Residential Care Facilities

Where available contact local occupational health department

Contact local public health team

Follow guidance on  - Occupational health Guidance

Infection Prevention and Control Management for following scenarios:

Note. Implementing infection prevention and control practice is extraordinarily difficult with residents who are unable to comply with requests from staff. In that setting the only practical approach is to apply the key principles of infection control as much as possible. These are to limit contact with others as much as possible, particularly in confined space, maintain a distance of at least 1 m (2 m when possible) of more whenever possible, practice hand hygiene, keep your hands away from your face

  • SCENARIO 1: Management of a Resident who is identified as a COVID- 19 Contact


  1.  (No symptoms): Such residents should be requested to avoid communal areas and wait in their room for their period of observation (until 14 days after exposure) and until Public Health advice confirms the resident can resume normal activity
  2. Residents may go outside if appropriate, alone or accompanied by a staff member maintaining a distance of at least 1m (2m when possible)
  3. Staff members who can avoid physical contact and maintain a distance of at least 1 m do not require apron, gloves or mask but should attend to hand hygiene
  4. Standard precautions should be used at all times for all patients in particular hand hygiene. Staff members providing direct care should wear plastic apron and gloves as per standard precautions. Surgical masks should be reserved for the care of residents who are coughing and sneezing. Where possible limit time (interventions of 15 mins) and distance exposure( 1m)
  5. Staff members should monitor at least twice per day and record if the resident has developed symptoms of infection
  6. Testing should be considered in residents who
    1. develop clinical features consistent with the current case definition (sudden onset of temperature (above 38C) without other apparent explanation or other relevant symptoms of acute respiratory tract infection
  7. Testing for COVID-19 is not indicated in residents with new features of undifferentiated illness or long standing stable cough or shortness of breath for which there is an another clinically apparent cause.
  • SCENARIO 2: Management of a resident who develops fever (above 38C) or symptoms of acute respiratory tract.


  1. Such residents should be requested to avoid communal areas and wait in their room until assessed.
  2. Contact the relevant Person In Charge / ADON/ DON/ Senior Staff member
  3. Perform a risk assessment by phone with GP/ MO /OOH
  4. Maintain a strong index of suspicion for likely COVID-19 positive disease in RCF with existing COVID-19 residents and follow isolation protocols accordingly.
  5. If testing for COVID-19 is required the GP or Medical Officer will arrange testing through the National Ambulance Service home testing service.
  6. Where COVID-19 is not suspected to be the primary cause of symptoms, and testing is not considered appropriate the resident should avoid communal areas until 48 hours after resolution of respiratory symptoms or fever or until another cause of fever that does not requires specific infection prevention and control precautions is apparent
  7. Residents may go outside alone if appropriate accompanied by a staff member maintaining a distance of 1m if appropriate
  8. Staff members providing direct care that requires approach within 1m of the resident in addition to Standard Precautions should wear plastic apron gloves and surgical mask pending confirmation of Covid-19 status
  9. Staff members who can avoid physical contact and maintain a distance of 1 m do not required apron, mask or gloves but should attend to hand hygiene
  10. If testing for COVID is considered necessary, then proceed as below regarding suspect Covid-19 case.
  • SCENARIO 3: Management when testing of a resident for Covid-19 is considered necessary (Suspect Case)     

Guidance: The resident should be considered as a suspect Covid-19 case

  1. The resident should avoid communal areas but may go outside alone or accompanied by a staff member maintaining a distance of 1m if appropriate
  2. Group activities should be suspended pending test results
  3. Residents should stay in their room as much as possible and minimise contact with other residents pending test results
  4. Residents should be encouraged to perform hand hygiene and respiratory hygiene and cough etiquette
  5. Healthcare workers should increase their attention to hand hygiene and respiratory hygiene and cough etiquette
  6. Visiting should be restricted to absolute necessity (for example end of life care)
  7. Public health should be informed and testing should be arranged according to the agreed process as quickly as possible
  8. Care for the resident who is awaiting testing should be delivered by a single nominated person on each shift
  9. If more than one resident requires testing consider feasibility of having one nominated person on each shift care for those residents awaiting testing
  10. In addition to Standard Precautions, the person caring for the resident should use apron, gloves and a surgical mask when within 1 m of the resident
  11. The resident should be encouraged to wear a surgical mask if available or otherwise, if possible, to cover the mouth and nose with a tissue when a staff member is within 1 m
  12. In addition to standard precautions if delivering direct care of the resident (close physical contact), contact & droplet precautions should be applied (staff members should wear a gown, surgical mask, and gloves and eye-protection if there is an assessed risk of splashing of blood or body fluids)
  13. If the test is reported not-detected management of the resident should be as for other respiratory tract infection
  • SCENARIO 4: Management if a resident tests positive for Covid-19     


  1. All group activities should be suspended
  2. The resident should avoid communal areas until 48 hours after resolution of symptoms, but may go outside alone if appropriate or accompanied by a staff member maintaining a distance of 1m if appropriate
  3. Staff members who can avoid physical contact and maintain a distance of at least 1 m do not require apron, mask or gloves but should attend to hand hygiene
  4. Residents should be encouraged to perform hand hygiene and respiratory hygiene and cough etiquette
  5. Healthcare workers should increase their attention to hand hygiene and respiratory hygiene and cough etiquette
  6. Visiting should be restricted to absolute necessity (for example end of life care)
  7. Care for the resident who has tested positive should be delivered by a single nominated person on each shift
  8. If more than one resident has tested positive consider feasibility of having one nominated person on each shift care for those residents who have tested positive and any patients awaiting testing
  9. In addition to Standard Precautions, staff who are providing direct care need to implement Contact and Droplet precautions ( apron, gloves and a surgical mask) when within 1 m of the resident for a brief period to perform a simple task
  10. The resident should be encouraged to wear a surgical mask if available or otherwise, if possible, to cover the mouth and nose with a tissue when a staff member is within 1m.
  11. If care of the resident requires close physical contact, in addition to Standard Precautions, staff members should wear a gown, surgical mask, and gloves and eye-protection if there is an assessed risk of splashing of blood or body fluids


  • SCENARIO 5: Management if more than one resident tests positive  for Covid-19 i.e. potential Covid-19 outbreak [ Note that this applies where it appears that Covid-19 was acquired while a patient in in the RCF]

Guidance : Management as per resident tests positive for Covid-19 plus following:

  1. Public Health should be informed as soon as possible of all suspected and confirmed outbreaks of Covid-19. (This is a legal obligation)
  2. HIQA will also require notification (NF02 form)
  3. A decision to convene an outbreak control team will be agreed between the Residential care facility and Public Health.
  4. Daily Outbreak Control Team OCT meetings are likely (at least initially) to report on outbreak control measures and updates on potential and confirmed new cases
  5. Outbreak control measures should be implemented as soon as possible
  6. Residential care facility staff must ensure that Standard Precautions are reinforced and Droplet and Contact Precautions are implemented immediately, if not already in place
  7. Identify appropriate area for isolating and cohorting of isolated cases where possible
  8. Local hospitals and National Ambulance Service notified (in event of anticipated patient transfer) by senior nurse in charge.
  9. Identified outbreaks should be notified to GP/ MO/ OOH services
  10. GP / MO and DON to liaise with local treating acute hospital physicians where appropriate in decisions re transfers
  11. Monitor clinical condition for change and follow national guidance on criteria for hospital admission where this is the ongoing treatment plan
  12. Care planning should reinforce all infection prevention and control measures to cover eventuality of hospital / other facility transfer
  13. Consider cancelling non-essential outward movement of residents
  14. Close the facility to new residents and transfers if possible
  15. Consider closing the facility to all non-essential visitors
  • SCENARIO 6: Death in the residential setting: When a resident dies (Covid-19 positive)

Coroner:  Refer to statement from the Coroners Society of Ireland version1. Dated 11/03/2020

Guidance: Use the HSE guidance documents on Verification and Pronouncement and Death

As Covid-19 is a new and emerging pathogen it is understandable that those who will be handling the remains will be concerned and may wish to be made aware of the patient’s infectious status.


  • Embalming is not recommended.

Hygienic preparation

  • Any infection control procedures that have been advised before death must be continued in handling the deceased person after death
  • Hygienic preparation includes washing of the face and hands, closing the mouth and eyes, tidying the hair and in some cases shaving the face.
  • Washing or preparing the body is acceptable if those carrying out the task wear long-sleeved gowns gloves , a surgical mask and eye protection if there is a risk of splashing) which should then bed is discarded.

Transporting the deceased person

  • Bodies should be placed in a body bag prior to transportation to the mortuary as this facilitates lifting and further reduces the risk of infection.
  • A face mask or similar should be placed over the mouth of the deceased before lifting the remains into the body bag.
  • Those physically handling the body and placing the body into the bag should wear, at a minimum, the following PPE:
    • Gloves
    • Long sleeved gown
    • Surgical facemask
    • Play close attention to washing hands after removal of PPE

Once in the hospital mortuary, it would be acceptable to open the body bag for family viewing only. The family should be advised not to kiss the deceased and should clean their hands with alcohol hand rub or soap and water after touching the deceased

PPE is not required for transfer once the body has been placed in the coffin

See guidance document for funeral directors in the HPSC website.

Interim Guidance on the use of oxygen in long term residential care settings for older people during the Covid-19 pandemic (CD19-076 V1.0 /14.04.20)

Interim Guidance on the use of oxygen in long term residential care settings for older people during the Covid-19 pandemic 

  • This document was written by National Clinical Programme for Respiratory (NCPR) and approved by the Clinical lead Dr Des Murphy and the Irish College of General Practitioners (ICGP) leads; Dr Mark O’ Kelly and Dr Dermot Nolan.  It has been approved and endorsed by Dr Siobhán Kennelly, National Clinical & Advisory Group Lead, Older Persons, HSE and by Dr David Hanlon, National Clinical and Advisory Group Lead, Primary Care, HSE.
  • Target audience: GPs and nursing home prescribers and staff.


  • The primary pathology causing death in patients with Covid-19is respiratory failure as a result of a viral pneumonia. Viral myocarditis has also been reported as a cause of up to one third of deaths. Secondary bacterial infections are rarely reported. Death is more common in those with significant frailty or co-morbidities with lower physiological reserve.
  • In the absence of effective anti-viral therapy, management in any setting is primarily symptomatic and supportive. As the disease can progress rapidly or unexpectedly, advance care plans including decisions on ceilings of care should be documented in advance of decisions regarding oxygen treatment.

The role of supplemental oxygen

  • Recent evidence suggests that supplemental oxygen has only a limited role in the management of Covid-19 n care settings outside acute hospitals. Oxygen may have some value in supporting patients with respiratory and cardiac morbidity, where it should be titrated against oxygen saturation levels and knowledge of background co-morbid disease, in particular COPD where Type 2 respiratory failure is more common.
  • There is consensus amongst palliative care physicians that oxygen does not typically improve symptoms of breathlessness at end of life where the approach should instead be the provision of appropriate supportive palliative medications (see CG Management of severe breathlessness). This often needs to be explained to carers and relatives

Prescribing oxygen

  • Oxygen is a treatment for hypoxia and should be prescribed in the medication kardex by the registered medical practitioner or nurse prescriber. All changes to prescription / flow rate must be discussed with the prescriber.
  • Maximum titration flow in care settings outside hospital is 4 l/min. When supporting a patient with Covid-19 for recovery with oxygen, supplementary oxygen can be commenced when saturations are less than 94%. The oxygen should then be titrated to achieve a target of 94%-96% in those patients who do not also have COPD.
  • In patients being treated for Covid-19 with a co-morbidity of COPD, oxygen saturations should be targeted at 90 - 94% due to the risk of Type 2 respiratory failure.

Related policies and staff competencies

  • Key policies and procedures to support the safe use and storage of oxygen should be in place and all staff should be trained in same.
  • Staff should be trained and aware of IPC procedures in relation to oxygen use.
  • Staff should be trained in appropriate palliative measures to ease severe breathlessness in setting of Covid-19.

back to table of contents for the use of oxygen in long term residential care settings 

Interim guidance VTE prevention in people with COVID19 in community or residential settings (CD19-176 / 25.05.20)


  • There are emerging reports of increased rates of venous thromboembolism (VTE, consisting of deep vein thrombosis DVT and/or pulmonary embolism PE) in patients hospitalised with COVID-19, particularly those with severe disease in critical care. The HSE Covid-19 Interim Clinical Guidance - VTE protocol and patient information for acute hospitals provides guidance in this setting.
  • There is a lack of evidence or data about the risk of VTE or appropriate prevention in people with COVID 19 in the community or residential settings. This guidance aims to clarify the circumstances under which VTE prevention may be considered in people with COVID-19 and what prevention may be appropriate.
  • The risk of VTE is not known to be raised in people with mild COVID-19. For clinical reasons and in keeping with the resident’s preference, some people in residential settings receive medical treatment there for moderate or severe COVID-19 illness. VTE risk may be increased in this group.
  • VTE prophylaxis is not routinely recommended in the community or in residential settings for people who do not have COVID-19.
  • VTE prophylaxis is not recommended in the community or in residential settings for people who have asymptomatic or mild COVID-19.
  • People with moderate or severe COVID-19 in the community or in residential settings who are transferred to hospital should be risk assessed and receive prophylaxis in hospital.
  • Pending the emergence of further evidence and on an interim basis, VTE prophylaxis may be considered in people with significant functional decline from baseline due to COVID-19 who are remaining in a residential setting. The senior clinical decision maker (in most cases the person’s GP) may consider whether prophylaxis is appropriate on an individual basis in this population, having regard for the resident’s treatment goals and care plan, and the balance of potential benefits and bleeding risks.

Reducing the risk of VTE

  • Encourage adequate hydration. Encourage movement/mobilising where possible.
  • Encourage awareness of VTE. Signs and symptoms of deep venous thrombosis, DVT, include pain, swelling, warmth or redness in one leg or calf. Signs and symptoms of pulmonary embolism, PE, include shortness of breath, rapid breathing, chest pain particularly on breathing deeply, coughing or coughing up blood. Immediate action to seek medical help is needed if they occur.

Low Molecular Weight Heparin (LMWH)

  • LMWH is recommended first line for VTE prophylaxis.
  • Consider contra-indications or cautions to LMWH prophylaxis:
    • Do not add LMWH prophylaxis if the person is on therapeutic anticoagulation, e.g. with warfarin (Warfant, Warfarin Teva), apixaban (Eliquis), dabigatran (Pradaxa), rivaroxaban (Xarelto), edoxaban (Lixiana), enoxaparin (e.g. Clexane) or tinzaparin (Innohep). Continue pre-existing therapeutic anticoagulation in this case.
    • Do not use LMWH if the person is actively bleeding or known to have a significant bleeding risk, e.g. is known to have a baseline platelet count less than 50 x 109/L, known inherited or acquired bleeding disorder, blood pressure 230 mmHg systolic or 120 mmHg diastolic or greater, or history of heparin-induced thrombocytopaenia (HIT). 
    • Consider if other bleeding risks outweigh the benefits of prophylaxis, e.g. medication such as non-steroidal anti-inflammatory drugs (NSAIDs) or dual antiplatelet therapy.
  • Ideally refer to a recent FBC and U&Es (within the last 8 weeks), however clinical judgement can be used.  If there is a concern about the need for blood monitoring before LMWH is prescribed, samples can be taken on the next working day.
  • Standard dose: Enoxaparin 40 mg once daily or tinzaparin 4,500 units once daily, by subcutaneous injection, while the person is considered at high risk of VTE, usually for a maximum of 14 days. 
  • Low body weight (less than 50 kg): Consider enoxaparin 20 mg or tinzaparin 3,500 units once daily.
  • Renal impairment: Consider enoxaparin 20 mg once daily if creatinine clearance 15-30 mL/min. If creatinine clearance less than 15 mL/min, consider mechanical prophylaxis. 

Mechanical prophylaxis

  • If prophylaxis is indicated but LMWH is not appropriate, graduated compression (anti-embolism) stockings may be considered while the person is considered at high risk of VTE, usually for 14 days.
  • Avoid graduated compression stockings in peripheral arterial disease, severe dermatitis, severe leg oedema or pulmonary oedema from congestive cardiac failure, leg deformity preventing correct fit, peripheral neuropathy, recent skin graft, allergy to fabric or acute stroke. Use caution and clinical judgement if applying stockings over venous ulcers or wounds.


Guidance development group

  • Ms Ciara Kirke: Clinical Lead, Medication Safety, National Quality Improvement Team
  • Ms AnnMarie O’Neill: CEO, Thrombosis Ireland
  • Prof Fionnuala Ni Ainle: Consultant Haematologist, Mater Hospital and Rotunda Hospital
  • Dr Denis O’Keeffe: Consultant Haematologist, University Hospital Limerick; Co-Chair, VTE Ireland 
  • Dr Niamh O’Connell: Consultant Haematologist, St James’s Hospital
  • Ms Niamh O’Hanlon: Chief II Pharmacist, St Vincent’s University Hospital
  • Ms Deirdre Lang: Director of Nursing, National Clinical Programme for Older Persons
  • Ms Elaine Brown: Project Manager, Office of the NCAGL Acute Operations
  • Dr David Hanlon: NCAGL Primary Care and GP
  • Dr Siobhan Kennelly: NCAGL Older Persons and Consultant Geriatrician, Connolly Hospital
  • Dr Diarmuid Quinlan: ICGP HSE Primary Care Lead for Diabetes, Integrated Care Programmes and GP
  • Dr Alan Martin: Consultant Geriatrician, Beaumont Hospital
  • Prof Mike Watts: Consultant Physician, University Hospital Limerick and Co-Chair, VTE Ireland
  • Ms Therese Dalchan: General Manager, AMRIC, Acute Operations
  • Dr Lucinda Dockeray: Chair, ICGP Residential and Nursing Homes Group and GP
  • Ms Judy Ryan: Director, Nursing and Midwifery Practice Development Unit, South East
  • Ms Muriel Pate: Specialist Pharmacist, Medication Safety, National QI Team
  • Ms Irene O’Hanlon: Quality & Patient Safety, Community Operations

National Health Library & Knowledge Service. Health Service Executive. Dr. Steevens' Hospital, Dublin 8. Tel: 01-6352555/8. Email: